Hopefully this one gets FDA approval in June 2024. I like that their drug Imetelstat is having a prolonged affect of transfusion independence on the 40% of respondents from their phase 3 Imerge Study. I have been adding shares like crazy, as I believe they have the best drug in the world in treating MDS(type of luekemia) and in fact, quadrupled my position in Wadegarret portfolio from 20K to over 80K shares !